ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RENB Renovaro Inc

1.54
0.09 (6.21%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Renovaro Inc NASDAQ:RENB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.09 6.21% 1.54 0.82 1.65 1.65 1.445 1.46 735,800 05:00:06

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

25/01/2024 5:45pm

GlobeNewswire Inc.


Renovaro (NASDAQ:RENB)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Renovaro Charts.

Renovaro Biosciences Inc. (NASDAQ: RENB) (the “Company”), a biotechnology corporation focusing on cell, gene, and immunotherapy, announced today the results of the Company’s Special Meeting of Shareholders held at 12:00 pm ET on January 25, 2024.

All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated January 3, 2024, were approved by the requisite number of votes cast at the meeting.

For complete results on all matters voted on at the meeting, please consult the Company's Form 8-K which will be filed on EDGAR at www.sec.gov/edgar.

ABOUT THE COMPANYRenovaro has developed advanced cell, gene, and immunotherapy platforms designed to renew the body’s natural tumor-fighting capabilities against cancer and infectious diseases. For more information on Renovaro, go to their website at www.renovarobio.com.

Contact: ir@renovarobio.comSource: Renovaro Bioscience Inc.

1 Year Renovaro Chart

1 Year Renovaro Chart

1 Month Renovaro Chart

1 Month Renovaro Chart

Your Recent History

Delayed Upgrade Clock